Kestra Medical Technologies Stock Net Income
| KMTS Stock | 24.71 1.11 4.70% |
As of the 22nd of January, Kestra Medical secures the Risk Adjusted Performance of 0.0228, mean deviation of 2.64, and Downside Deviation of 3.93. Kestra Medical Technologies technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices. Please verify Kestra Medical Techn information ratio and downside variance to decide if Kestra Medical Technologies is priced some-what accurately, providing market reflects its recent price of 24.71 per share. Given that Kestra Medical Techn has jensen alpha of (0.08), we recommend you to check Kestra Medical's last-minute market performance to make sure the company can sustain itself at a future point.
Kestra Medical Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 16.808 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -102.4 M | -107.6 M | |
| Net Loss | -102.4 M | -107.6 M | |
| Net Loss | (2.64) | (2.77) | |
| Net Income Per E B T | 1.15 | 1.10 |
Kestra | Net Income | Build AI portfolio with Kestra Stock |
Latest Kestra Medical's Net Income Growth Pattern
Below is the plot of the Net Income of Kestra Medical Technologies over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Kestra Medical Techn financial statement analysis. It represents the amount of money remaining after all of Kestra Medical Technologies operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Kestra Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kestra Medical's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (113.81 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Kestra Net Income Regression Statistics
| Arithmetic Mean | (53,833,402) | |
| Coefficient Of Variation | (63.41) | |
| Mean Deviation | 30,987,814 | |
| Median | (29,467,000) | |
| Standard Deviation | 34,135,716 | |
| Sample Variance | 1165.2T | |
| Range | 84.3M | |
| R-Value | (0.85) | |
| Mean Square Error | 334.8T | |
| R-Squared | 0.73 | |
| Significance | 0.000012 | |
| Slope | (5,778,110) | |
| Total Sum of Squares | 18644T |
Kestra Net Income History
Other Fundumenentals of Kestra Medical Techn
Kestra Medical Net Income component correlations
Kestra Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Kestra Medical is extremely important. It helps to project a fair market value of Kestra Stock properly, considering its historical fundamentals such as Net Income. Since Kestra Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Kestra Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Kestra Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kestra Medical. If investors know Kestra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kestra Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.96) | Revenue Per Share | Quarterly Revenue Growth 0.534 | Return On Assets | Return On Equity |
The market value of Kestra Medical Techn is measured differently than its book value, which is the value of Kestra that is recorded on the company's balance sheet. Investors also form their own opinion of Kestra Medical's value that differs from its market value or its book value, called intrinsic value, which is Kestra Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kestra Medical's market value can be influenced by many factors that don't directly affect Kestra Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kestra Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kestra Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kestra Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Kestra Medical 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kestra Medical's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kestra Medical.
| 10/24/2025 |
| 01/22/2026 |
If you would invest 0.00 in Kestra Medical on October 24, 2025 and sell it all today you would earn a total of 0.00 from holding Kestra Medical Technologies or generate 0.0% return on investment in Kestra Medical over 90 days. Kestra Medical is related to or competes with Azenta, Novocure, STAAR Surgical, BioLife Solutions, Wave Life, Pulse Biosciences, and Neogen. Kestra Medical is entity of United States More
Kestra Medical Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kestra Medical's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kestra Medical Technologies upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.93 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 20.54 | |||
| Value At Risk | (7.02) | |||
| Potential Upside | 4.7 |
Kestra Medical Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kestra Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kestra Medical's standard deviation. In reality, there are many statistical measures that can use Kestra Medical historical prices to predict the future Kestra Medical's volatility.| Risk Adjusted Performance | 0.0228 | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.41) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0415 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kestra Medical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Kestra Medical January 22, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0228 | |||
| Market Risk Adjusted Performance | 0.0515 | |||
| Mean Deviation | 2.64 | |||
| Semi Deviation | 3.85 | |||
| Downside Deviation | 3.93 | |||
| Coefficient Of Variation | 5003.25 | |||
| Standard Deviation | 3.72 | |||
| Variance | 13.87 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.08) | |||
| Total Risk Alpha | (0.41) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0415 | |||
| Maximum Drawdown | 20.54 | |||
| Value At Risk | (7.02) | |||
| Potential Upside | 4.7 | |||
| Downside Variance | 15.43 | |||
| Semi Variance | 14.84 | |||
| Expected Short fall | (2.56) | |||
| Skewness | 0.0849 | |||
| Kurtosis | 1.6 |
Kestra Medical Techn Backtested Returns
Kestra Medical Techn has Sharpe Ratio of close to zero, which conveys that the firm had a close to zero % return per unit of risk over the last 3 months. Kestra Medical exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Kestra Medical's Mean Deviation of 2.64, risk adjusted performance of 0.0228, and Downside Deviation of 3.93 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.55, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Kestra Medical will likely underperform. At this point, Kestra Medical Techn has a negative expected return of -0.0166%. Please make sure to verify Kestra Medical's downside variance, as well as the relationship between the daily balance of power and relative strength index , to decide if Kestra Medical Techn performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.31 |
Below average predictability
Kestra Medical Technologies has below average predictability. Overlapping area represents the amount of predictability between Kestra Medical time series from 24th of October 2025 to 8th of December 2025 and 8th of December 2025 to 22nd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kestra Medical Techn price movement. The serial correlation of 0.31 indicates that nearly 31.0% of current Kestra Medical price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.31 | |
| Spearman Rank Test | 0.25 | |
| Residual Average | 0.0 | |
| Price Variance | 2.95 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Kestra Net Interest Income
Net Interest Income |
|
Based on the recorded statements, Kestra Medical Technologies reported net income of (113.81 Million). This is 133.35% lower than that of the Health Care Equipment & Supplies sector and 214.23% lower than that of the Health Care industry. The net income for all United States stocks is 119.93% higher than that of the company.
Kestra Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kestra Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kestra Medical could also be used in its relative valuation, which is a method of valuing Kestra Medical by comparing valuation metrics of similar companies.Kestra Medical is currently under evaluation in net income category among its peers.
Kestra Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Kestra Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Kestra Medical's managers, analysts, and investors.Environmental | Governance | Social |
Kestra Fundamentals
| Return On Equity | -1.26 | ||||
| Return On Asset | -0.44 | ||||
| Profit Margin | (1.78) % | ||||
| Operating Margin | (1.41) % | ||||
| Current Valuation | 1.25 B | ||||
| Shares Outstanding | 58.35 M | ||||
| Shares Owned By Insiders | 5.47 % | ||||
| Shares Owned By Institutions | 84.68 % | ||||
| Number Of Shares Shorted | 2.41 M | ||||
| Price To Book | 8.40 X | ||||
| Price To Sales | 18.54 X | ||||
| Revenue | 59.81 M | ||||
| Gross Profit | 34.46 M | ||||
| EBITDA | (97.98 M) | ||||
| Net Income | (113.81 M) | ||||
| Total Debt | 44.31 M | ||||
| Book Value Per Share | 3.19 X | ||||
| Cash Flow From Operations | (77.61 M) | ||||
| Short Ratio | 5.45 X | ||||
| Earnings Per Share | (3.96) X | ||||
| Target Price | 29.0 | ||||
| Number Of Employees | 330 | ||||
| Market Capitalization | 1.38 B | ||||
| Total Asset | 295.74 M | ||||
| Retained Earnings | (520.25 M) | ||||
| Working Capital | 217.35 M | ||||
| Net Asset | 295.74 M |
About Kestra Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kestra Medical Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kestra Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kestra Medical Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Kestra Stock Analysis
When running Kestra Medical's price analysis, check to measure Kestra Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kestra Medical is operating at the current time. Most of Kestra Medical's value examination focuses on studying past and present price action to predict the probability of Kestra Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kestra Medical's price. Additionally, you may evaluate how the addition of Kestra Medical to your portfolios can decrease your overall portfolio volatility.